SAN MATEO, Calif., March 12, 2025 /PRNewswire/ — Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback